Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares stood at 0.54 million during the last session, with the company’s beta value hitting -0.76. At the close of
Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares stood at 1.14 million during the last session, with the company’s beta value hitting -0.54. At the close of
In the last trading session, 1.08 million Candel Therapeutics Inc (NASDAQ:CADL) shares changed hands as the company’s beta touched -0.66. With the company’s per share
In last trading session, Candel Therapeutics Inc (NASDAQ:CADL) saw 1.4 million shares changing hands with its beta currently measuring -0.94. Company’s recent per share price
In the last trading session, 2.51 million shares of the Candel Therapeutics Inc (NASDAQ:CADL) were traded, and its beta was -1.15. Most recently the company’s
Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares stood at 1.08 million during the last session, with the company’s beta value hitting -1.20. At the close of
In the last trading session, 1.02 million Candel Therapeutics Inc (NASDAQ:CADL) shares changed hands as the company’s beta touched -1.05. With the company’s per share
During the last session, Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares were 0.64 million, with the beta value of the company hitting -1.17. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
